1. Detection of serum histamine-releasing factors in a patient with idiopathic anaphylaxis and multiple drug allergy syndrome.
- Author
-
Tedeschi A, Lorini M, Suli C, and Cugno M
- Subjects
- Adult, Anaphylaxis blood, Anti-Bacterial Agents immunology, Drug Hypersensitivity blood, Drug Hypersensitivity diagnosis, Drug Hypersensitivity immunology, Female, Humans, Syndrome, Tumor Protein, Translationally-Controlled 1, Anaphylaxis immunology, Biomarkers, Tumor blood, Cetirizine therapeutic use, Drug Hypersensitivity prevention & control, Histamine H1 Antagonists, Non-Sedating therapeutic use, Skin Tests methods
- Abstract
We describe the case of a 30-year-old woman who reported several episodes of anaphylaxis with angioedema and relapsing urticaria. Some events were related to nonsteroidal anti-inflammatory drug intake and one episode followed alcohol ingestion, but in most cases no triggers could be identified. Specific immunoglobulin E determination was negative for food and drug allergens, C3 and C4 were in the normal range, C1 inhibitor was slightly reduced and serum tryptase was undetectable. In vivo autologous serum skin test and in vitro basophil histamine release assay were positive indicating the presence of circulating histamine-releasing factors. When oral tolerance tests were performed, only doxycycline was tolerated whereas levofloxacin, clarithromycin, nimesulide and tramadol caused mild urticaria. Premedication with cetirizine allowed the patient to tolerate levofloxacin, clarithromycin and nimesulide. The demonstration of circulating histamine-releasing factors in a patient with idiopathic anaphylaxis and multiple drug allergy syndrome provides a new mechanistic insight and might open the way to new therapeutic approaches.
- Published
- 2007